Product Images Palynziq
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 31 images provide visual information about the product associated with Palynziq NDC 68135-673 by Biomarin Pharmaceutical Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - palynziq 1
This is a table showing the mean observed blood phenylalanine levels in micromol/L for a study (Study 302) that was randomized and tested a drug called Palynziq at different doses (20mg and 40mg) compared to a placebo. The table shows the different time points when these measurements were taken: pre-treatment baseline, withdrawal baseline, withdrawal week 4, and withdrawal week 8.*
Figure I - palynziq 10
Figure J - palynziq 11
Figure K - palynziq 12
Figure L - palynziq 13
Figure M - palynziq 14
Figure N - palynziq 15
Figure O - palynziq 16
Pinch Skin is a likely an instruction or a phrase that refers to the act of pinching the skin. The context and purpose of pinching the skin are not available.*
Figure P - palynziq 17
This appears to be a set of instructions for a medical procedure involving moving one's hand into a position ready for needle injection.*
Figure Q - palynziq 18
Figure R - palynziq 19
Figure A - palynziq 2
Figure S - palynziq 20
Figure T - palynziq 21
2.5 mg Carton - palynziq 22
This appears to be a product description for a medication called Pegvaliase-palz, which comes in a single-dose pre-filled syringe containing 2.5 mg/0.5mL, and is intended for subcutaneous use only. The medication should be stored in the refrigerator between 2°C to 8°C, and protected from light. If needed, the medication can be stored at room temperature between 20°C to 25°C for up to 30 days, but should not be placed back in the refrigerator after that time. The syringe also contains sodium chloride, trans-cinnamic acid, and tromethamis. There is further information related to prescribing information that is not available in the text.*
2.5 mg Tray Cover - palynziq 23
This is a description of Palemziq, an injection medication administered subcutaneously using a single-use pre-filled syringe. Each syringe contains 2.5 mg/0.5 mL of the medication and is for one-time use only. The medication comes in a carton that must be refrigerated at 36°F to 46°F (2°C to 8°C) to protect it from light and should not be frozen or shaken. There is no preservative in the medication, and the usual dosage can be found in the prescribing information. The NDC number is 68135.056-80 Rxonly.*
2.5 mg Syringe Label - palynziq 24
Palynziq is a medication with the drug name pegvaliase-papz. Additional information is not available.*
10 mg Carton - palynziq 25
This appears to be a description for a medication called "pegvaliasa-papz" that comes in a single-dose pre-filled syringe. The medication guide and instructions for use should be provided to each patient, and it is only intended for subcutaneous use. It should be stored in a refrigerator between 2°C and 8°C (36°F to 46°F) and should not be frozen or shaken. The usual dosage is 10mg delivered in 0.5 mL. The medication contains sodium chloride, trans-cinnamic acid, and tromethamine hydrochloride. There are no preservatives included.*
10 mg Tray Cover - palynziq 26
This text provides limited information regarding a medical product named NOG eB135.756.10 in the form of a prefilled syringe with a dosage of 10mg/0.5mL. It is intended for subcutaneous use only. There are instructions provided regarding the handling and storage of the product, including protecting it from light, not freezing or shaking it, and discarding it after use. However, there is little information regarding the active ingredients or the purpose of the medication.*
10 mg Syringe Label - palynziq 27
20 mg Carton - palynziq 28
This is the description of a medication product called Palyniq. It is a 20mg/mL solution for subcutaneous use only. The product is stored in the refrigerator at a temperature of 2°C to 8°C to protect it from light. It should not be frozen or shaken. Palyniq may be stored at room temperature between 20°C to 25°C for up to 30 days. The single-dose prefilled syringe contains 20mg pegallass-papzin 1mL and some inactive ingredients such as sodium chiorids, trans-cinnarmic acid, tromethamins and tromethamins hycroshiorde. The carton includes one tray with syringe, prescribing information, medication guide and instructions for use. The usual dosage is described in the prescribing information.*
20 mg Tray Cover - palynziq 29
Product Name: Palynzic. This is a prescription drug with NDC number 68135-673-30. It is used for subcutaneous administration only. The drug comes in a single-dose prefilled syringe and the concentration is 120 mgmL. The carton should be protected from light and should not be frozen or shaken to prevent damage. The drug must be discarded after use.*
Figure B - palynziq 3
This appears to be a list of components or features related to a medical syringe. It includes a "Viewing Plunger", a "Needle Cap Window", a "Plunger Head", a "Syringe Finger", and "Label Grips". It is not clear from this text what these components do or how they work together.*
20 mg Syringe Label - palynziq 30
Palynziq™ is a medication with the active ingredient pegvaliase-pqpz. Further information is not available from the provided text.*
20 mg Carton (Multi Pack) - palynziq 31
Figure C - palynziq 4
This document appears to be a chart or table listing different strengths of medication in milligrams and their corresponding colors. The available information includes 2.5mg in white, 10mg in green, and 20mg in blue.*
Figure D - palynziq 5
Figure E - palynziq 6
Figure F - palynziq 7
Figure G - palynziq 8
Figure H - palynziq 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.